Aurinia Pharmaceuticals (AUPH) Reports Financial Results for Three and Twelve Months Ended December 31, 2025
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) is one of the best cheap biotech stocks to buy now. Aurinia Pharmaceuticals Inc.
Aurinia Pharmaceuticals Inc. (AUPH)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Tang Capital Management Kevin C. Tang | 12,229,500 | $181,241,190 | +8% | 9.2% |
| 2. | Two Sigma Advisors John Overdeck And David Siegel | 3,428,705 | $50,813,408 | +163% | 0.04% |
| 3. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 3,284,368 | $48,674,334 | -4% | 0.03% |
| 4. | Marshall Wace LLP Paul Marshall And Ian Wace | 1,874,597 | $27,781,530 | +20% | 0.03% |
| 5. | Renaissance Technologies Jim Simons | 1,663,835 | $24,658,035 | +5% | 0.04% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $15.28 | 206,005 | $3,147,756.40 | 13,044,106 | 2026-06-02 | Filing | |
| $15.34 | 99 | $1,518.66 | 12,838,101 | 2026-06-01 | Filing | |
| $15.28 | 343,521 | $5,249,000.88 | 12,838,002 | 2026-06-01 | Filing | |
| $15.31 | 262,682 | $4,021,661.42 | 12,494,481 | 2026-05-29 | Filing | |
| $15.35 | 2,299 | $35,289.65 | 12,231,799 | 2026-05-29 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.50 | 20,000 | $210,000.00 | 133,484 | 2025-08-01 | Filing | |
| $8.23 | 8,305 | $68,350.15 | 153,484 | 2025-03-07 | Filing | |
| $7.92 | 164,947 | $1,306,380.24 | 1,788,945 | 2025-03-04 | Filing | |
| $8.00 | 195,593 | $1,564,744.00 | 1,953,892 | 2025-03-03 | Filing | |
| $8.00 | 12,239 | $97,912.00 | 161,789 | 2025-03-03 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,845,521 | $116,270,621 | 0% | |
| 2. | 3,969,834 | $58,832,940 | 3.34% | |
| 3. | 2,527,099 | $37,451,607 | 0% | |
| 4. | 2,232,548 | $33,086,365 | 0% | |
| 5. | 1,536,009 | $22,760,482 | 0% |
News See All
12 Cheap Biotech Stocks to Buy Now
On February 27, Eli Casdin, Casdin Capital CEO, appeared on CNBC’s ‘Closing Bell’ to talk about the biotech sector.
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q4 2025 Earnings Call Transcript
Operator: Good morning. Welcome to the Aurinia Pharmaceuticals Fourth Quarter and Full Year 2025 Conference Call. Please be advised that a Q&A session will follow Aurinia prepared remarks.
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q3 2025 Earnings Call Transcript
Operator: Good morning. Welcome to the Aurinia Pharmaceuticals Third Quarter 2025 Conference Call.
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q2 2025 Earnings Call Transcript
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q2 2025 Earnings Call Transcript July 31, 2025Aurinia Pharmaceuticals Inc. misses on earnings expectations.
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q1 2025 Earnings Call Transcript
Operator: Greetings, and welcome to the Aurinia Pharmaceuticals Inc. Q1 2025 Earnings Call. At this time, all participants are in a listen-only mode.
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q4 2024 Earnings Call Transcript
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q4 2024 Earnings Call Transcript February 27, 2025Aurinia Pharmaceuticals Inc. misses on earnings expectations.
10 Best Small-Cap Growth Stocks to Buy Now
On November 4, 2024, Nick Sheridan, Portfolio Manager at Janus Henderson released a report on small-cap stocks exploring how these stocks offer unique growth and diversification opportunities.
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q3 2024 Earnings Call Transcript
Operator: Greetings, and welcome to Aurinia Pharmaceuticals Third Quarter 2024 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded.
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q2 2024 Earnings Call Transcript
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q2 2024 Earnings Call Transcript August 1, 2024Aurinia Pharmaceuticals Inc. misses on earnings expectations.